Stock overview
Merck & Co. Inc.
Explore the company, reported ownership, price history, and available source evidence.
Merck develops medicines and vaccines, with major businesses in oncology, infectious disease, and animal health.
- Last close
- $137.78
- · MRK
- Tracked holders
- 7 funds
- Latest available 13F per fund
MRK · USD
Price
Close · Nov 18, 2026
- Range low
- $94.97
- Range high
- $156.45
- Observations
- 252
- Session date
- Nov 18, 2026
Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Samlyn Capital largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | −4% 26'Q3 | $78,940,529 | 1.33% |
| Gotham Asset Management position history Q3 2026 · filed Nov 16, 2026 · SEC filing | +2% 26'Q3 | $78,619,830 | 0.16% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | Newly reported 26'Q3 | $61,432,709 | 0.08% |
| Fairfax Financial Holdings position history Q3 2026 · filed Nov 16, 2026 · SEC filing | — | $25,137,931 | 0.95% |
| Central Securities position history Q3 2026 · filed Nov 6, 2026 · SEC filing | — | $21,796,500 | 1.57% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
+4% 26'Q2 | $5,505,496 | 0.13% |
| Renaissance Technologies position history Q3 2026 · filed Nov 12, 2026 · SEC filing | Newly reported 26'Q3 | $632,802 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market